Lower limb muscle limitations hamper walking in diabetes
(HealthDay) -- In older adults, diabetes correlates with slower walking speed, and diabetes-linked reductions in muscle strength and worse muscle quality contribute to these walking limitations, according to a study published online May 17 in Diabetes Care.
Stefano Volpato, M.D., M.P.H., from the University of Ferrara in Italy, and colleagues conducted a cross-sectional analysis of 835 participants (aged 65 years old and older; diabetes prevalence, 11.4 percent) enrolled in a population-based study. Peripheral quantitative computerized tomography was used to assess total, muscular, and fat cross-sectional areas of the calf and relative muscle density. Knee extension torque, ankle plantar flexion and dorsiflexion strength, lower extremity muscle power, and ankle muscle quality were used as indicators of muscle performance. Gait was measured by the 4-m and 400-m walking speed tests.
The researchers found that participants with diabetes had significantly lower muscle density, knee and ankle strength, and muscle power, as well as worse muscle quality, after adjustment for age and gender. Participants with diabetes were significantly slower on both the 4-m and 400-m walking tests. In the 4-m and 400-m tests, lower limb muscle characteristics accounted for 24.3 and 15.1 percent, respectively, of the difference in the walking speed between individuals with and without diabetes.
"In older persons, diabetes is associated with reduced muscle strength and worse muscle quality," the authors write.
More information: Abstract
Full Text (subscription or payment may be required)
Journal reference:
Diabetes Care
Copyright © 2012 HealthDay. All rights reserved.
-
Dieting alone may not help stave off type 2 diabetes; muscle mass, strength important
May 27, 2010 |
not rated yet |
0
-
Older men with higher testosterone levels lose less muscle mass as they age
Oct 27, 2011 |
not rated yet |
0
-
Fewer mitochondria in offspring of parents with diabetes
Mar 26, 2012 |
not rated yet |
0
-
Better understanding arthritis
May 02, 2012 |
not rated yet |
0
-
Increased muscle mass may lower risk of pre-diabetes
Jul 28, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Find a link between physics and assignment problems
1 hour ago
-
Light as a source of electricity
1 hour ago
-
A question about the energy stored in a capacitor.
1 hour ago
-
Electric field-Charge inside a metallic shell
3 hours ago
-
Change in momentum when a body is thrown up and falls back down.
10 hours ago
-
change in speed and wavelength of light while travelling from one med
10 hours ago
- More from Physics Forums - Classical Physics
More news stories
Exercise prevents fructose-induced hypertriglyceridemia
(HealthDay)—Moderate aerobic exercise prevents fructose-induced hypertriglyceridemia in healthy males, according to a study published online May 14 in Diabetes.
Diabetes
May 17, 2013 |
5 / 5 (1) |
0
|
DNA variant affects diabetes risk and treatment response
A DNA variant near a digestive enzyme does not only affect risk of developing diabetes but also affects the response to treatment, an international consortium of researchers including the University of Dundee has found.
Diabetes
May 17, 2013 |
not rated yet |
0
|
The artificial pancreas that keeps tabs on sugar
(Medical Xpress)—Development of a sophisticated artificial pancreas holds potential to transform the lives of patients with Type 1 diabetes.
Diabetes
May 16, 2013 |
5 / 5 (1) |
0
|
Study findings significant for treating infections in Type 1 diabetes
A small University at Buffalo study has found for the first time that in Type 1 diabetics, insulin injections exert a strong anti-inflammatory effect at the cellular and molecular level, while even small amounts of glucose ...
Diabetes
May 16, 2013 |
not rated yet |
0
Hospital hypoglycemia rates up in black men with diabetes
(HealthDay)—Home diabetes regimens partially explain the increased risk of having a hypoglycemia event during hospitalization among older African-American men with diabetes, according to a study published ...
Diabetes
May 14, 2013 |
not rated yet |
0
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
Ginger compounds may be effective in treating asthma symptoms
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.